PT1301537E - Péptidos e sua utilização em ensaios para doença cardiovascular - Google Patents

Péptidos e sua utilização em ensaios para doença cardiovascular Download PDF

Info

Publication number
PT1301537E
PT1301537E PT01949734T PT01949734T PT1301537E PT 1301537 E PT1301537 E PT 1301537E PT 01949734 T PT01949734 T PT 01949734T PT 01949734 T PT01949734 T PT 01949734T PT 1301537 E PT1301537 E PT 1301537E
Authority
PT
Portugal
Prior art keywords
assays
peptides
cardiovascular disease
cyclised
affinity
Prior art date
Application number
PT01949734T
Other languages
English (en)
Inventor
Seppo Yla-Herttuala
Outi Narvanen
Original Assignee
Ark Therapeutics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Oy filed Critical Ark Therapeutics Oy
Publication of PT1301537E publication Critical patent/PT1301537E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT01949734T 2000-07-18 2001-07-18 Péptidos e sua utilização em ensaios para doença cardiovascular PT1301537E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0017641.2A GB0017641D0 (en) 2000-07-18 2000-07-18 Peptides and their use

Publications (1)

Publication Number Publication Date
PT1301537E true PT1301537E (pt) 2008-12-04

Family

ID=9895897

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01949734T PT1301537E (pt) 2000-07-18 2001-07-18 Péptidos e sua utilização em ensaios para doença cardiovascular

Country Status (12)

Country Link
US (2) US20040091934A1 (pt)
EP (1) EP1301537B1 (pt)
JP (1) JP2004504327A (pt)
AT (1) ATE408626T1 (pt)
AU (1) AU2001270851A1 (pt)
CA (1) CA2417789A1 (pt)
DE (1) DE60135846D1 (pt)
DK (1) DK1301537T3 (pt)
ES (1) ES2312455T3 (pt)
GB (1) GB0017641D0 (pt)
PT (1) PT1301537E (pt)
WO (1) WO2002006314A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105003A1 (en) 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
SE0103754L (sv) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
CN1283313C (zh) 2001-09-28 2006-11-08 埃斯佩里安医疗公司 α螺旋状载脂蛋白或HDL关联蛋白在制备局部给药预防和治疗再狭窄的药物中的用途
EP1732383A4 (en) 2004-04-06 2007-05-02 Cedars Sinai Medical Center PREVENTION AND TREATMENT OF VASCULAR DISEASES WITH VIRUS VECTORS ASSOCIATED WITH RECOMBINANT ADENOVIRUS CODING APOLIPOPROTEIN A-I AND APOLIPOPROTEIN A-I MILANO
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
JP5057402B2 (ja) * 2006-10-26 2012-10-24 アボット・ラボラトリーズ 内在性の抗分析物抗体を含有する試料中の分析物の免疫アッセイ
MX2009006744A (es) * 2006-12-22 2009-06-30 Abbott Lab Panel de padecimiento cardiovascular autoinmune y metodos de utilizacion del mismo.
EP2637689A2 (en) 2010-11-12 2013-09-18 Cedars-Sinai Medical Center Immunomodulatory methods and systems for treatment and/or prevention of hypertension
US9205139B2 (en) 2010-11-12 2015-12-08 Cardiovax, Llc Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
JP5857312B2 (ja) * 2011-08-11 2016-02-10 積水メディカル株式会社 心疾患診断マーカー
CN107085025B (zh) * 2016-02-15 2019-09-17 太原师范学院 一种自组装三层膜电极及其制备方法和用途
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
US10434141B2 (en) 2016-05-31 2019-10-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
CN111855986A (zh) * 2019-04-25 2020-10-30 常州博闻迪医药股份有限公司 联合定量检测五项心脏标志物试剂盒及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408038A (en) * 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
GB9609702D0 (en) * 1996-05-09 1996-07-10 Royal Free Hosp School Med Anticoagulant peptides
GB9705831D0 (en) * 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
CA2294355C (en) * 1997-06-20 2006-11-28 Leuven Research & Development Vzw Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins

Also Published As

Publication number Publication date
DK1301537T3 (da) 2008-12-08
ATE408626T1 (de) 2008-10-15
WO2002006314A3 (en) 2002-04-18
WO2002006314A2 (en) 2002-01-24
ES2312455T3 (es) 2009-03-01
US20040091934A1 (en) 2004-05-13
GB0017641D0 (en) 2000-09-06
EP1301537A2 (en) 2003-04-16
CA2417789A1 (en) 2002-01-24
US20080261234A1 (en) 2008-10-23
EP1301537B1 (en) 2008-09-17
JP2004504327A (ja) 2004-02-12
AU2001270851A1 (en) 2002-01-30
DE60135846D1 (de) 2008-10-30

Similar Documents

Publication Publication Date Title
PT1301537E (pt) Péptidos e sua utilização em ensaios para doença cardiovascular
DE69940429D1 (de) Peptidinhibitoren der ns3-protease des hepatoitis c virus
DE60144145D1 (de) Subtilisin-variante
MA26221A1 (fr) Nouveaux preconcentres de microemulsion d'analogue de la cyclosporine.
EP2518155A3 (en) Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
WO2002030959A3 (en) Peptides derived from smac (diablo) and methods of use therefor
HK1022700A1 (en) Crystallizable compositions comprising a hepatitis c virus ns3 protease domain/ns4a complex and crystals thereby obtained
KR880701728A (ko) 조직-형 및 우로키나제-형 플라스 미노겐 활성체 억제제의 진단검정 방법 및 억제제의 암호화 유전자
WO2002006457A3 (en) Novel lipase genes
WO2002018635A3 (en) Use of nonviable particles comprising an internal control (ic) nucleic acid
Tsushima et al. Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A
BR9811412A (pt) Variante de enzima subtilase tendo melhorado desempenho de lavagem em detergentes, sequência de dna isolada, vetor de expressão, célula hospedeira microbiana, processos para produzir uma variante e para identificar uma variante de protease, composição, e, uso de uma variante de subtilase
WO2003002730A3 (fr) Methode de detection de l'activite de la calpaine 3 dans un echantillon biologique et peptides pour la mise en oeuvre de ladite methode
WO2001006019A3 (en) Nucleic acids for detecting parvovirus and methods of using same
WO2002102847A1 (fr) Nouveau ligand et son adn
ATE310823T1 (de) Expressionssystem zur produktion von proteinen in pilzen
ATE510922T1 (de) Induzierbare promotoren
DE60225587D1 (de) Protease assay zur kontrolle medikamentöser therapie
NZ504633A (en) A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof
Ma et al. Proteolytic cleavage of the puromycin-sensitive aminopeptidase generates a substrate binding domain
WO2004046371A3 (en) Lipid phosphatase assays in disease and drug discovery
DE60029108D1 (de) Von zylklischem gmp-abhängige proteinkinase als chemotherapeutisches ziel für gegen protozoen gerichtete agenzien
WO2002044112A1 (fr) Procede de conception de la structure moleculaire d'un inhibiteur d'enzyme
CA2423294A1 (en) Method for synthesising peptides, peptide mimetics and proteins
Matsuo et al. C-Npys (S-3-nitro-2-pyridinesulfenyl) and peptide derivatives can inhibit a serine-thiol proteinase activity from Paracoccidioides brasiliensis